{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:51:06Z","timestamp":1793994666838,"version":"4.8.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.beem.2026.102107","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:12:30Z","timestamp":1777965150000},"page":"102107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lean metabolic dysfunction-associated steatotic liver disease: Current insights and knowledge gaps"],"prefix":"10.1016","volume":"40","author":[{"given":"Praveen Sandeep","family":"Raj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Manoharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asisha M.","family":"Janeela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.beem.2026.102107_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.beem.2026.102107_bib2","article-title":"Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD - reconciling the present with the past","volume":"3","author":"Ayonrinde","year":"2021","journal-title":"JHEP Rep"},{"issue":"6","key":"10.1016\/j.beem.2026.102107_bib3","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.beem.2026.102107_bib4","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.beem.2026.102107_bib5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2022.06.023","article-title":"AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review","volume":"163","author":"Long","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.beem.2026.102107_bib6","first-page":"126","article-title":"Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study","author":"Tan","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.beem.2026.102107_bib7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/hep4.1519","article-title":"Prevalence and profile of nonalcoholic fatty liver disease in lean adults: systematic review and meta-analysis","volume":"4","author":"Young","year":"2020","journal-title":"Hepatol Commun"},{"issue":"3","key":"10.1016\/j.beem.2026.102107_bib8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jceh.2021.11.010","article-title":"Prevalence of non-alcoholic fatty liver disease in india: a systematic review and meta-analysis","volume":"12","author":"Shalimar","year":"2022","journal-title":"J Clin Exp Hepatol"},{"issue":"3","key":"10.1016\/j.beem.2026.102107_bib9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s12072-023-10498-w","article-title":"Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis: a multi-centric study","volume":"17","author":"Prabhakar","year":"2023","journal-title":"Hepatol Int"},{"issue":"5","key":"10.1016\/j.beem.2026.102107_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12664-017-0785-x","article-title":"Risk factors for non-alcoholic fatty liver disease are common in patients with non-B non-C hepatocellular carcinoma in India","volume":"36","author":"David","year":"2017","journal-title":"Indian J Gastroenterol"},{"issue":"2","key":"10.1016\/j.beem.2026.102107_bib11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jceh.2021.05.008","article-title":"Prevalence of risk factors for nonalcoholic fatty liver disease in middle-aged and elderly patients with cryptogenic cirrhosis","volume":"12","author":"Bharath Kumar","year":"2022","journal-title":"J Clin Exp Hepatol"},{"issue":"i\u2013xii","key":"10.1016\/j.beem.2026.102107_bib12","first-page":"1","article-title":"Report of a WHO consultation","volume":"894","author":"Obesity: preventing and managing the global epidemic","year":"2000","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"5","key":"10.1016\/j.beem.2026.102107_bib13","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ijo.2010.5","article-title":"Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis","volume":"34","author":"Okorodudu","year":"2010","journal-title":"Int J Obes (Lond)"},{"issue":"10","key":"10.1016\/j.beem.2026.102107_bib14","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1038\/s41366-021-00858-7","article-title":"Normal weight obesity and unaddressed cardiometabolic health risk-a narrative review","volume":"45","author":"Wijayatunga","year":"2021","journal-title":"Int J Obes"},{"issue":"5","key":"10.1016\/j.beem.2026.102107_bib15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12170-013-0329-6","article-title":"Race\/ethnicity, obesity, and related cardio-metabolic risk factors: a life-course perspective","volume":"7","author":"Wahi","year":"2013","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"9403","key":"10.1016\/j.beem.2026.102107_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(03)15269-5","article-title":"The Y-Y paradox","volume":"363","author":"Yajnik","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.beem.2026.102107_bib17","first-page":"152","article-title":"The prevalence and predictors of non-alcoholic fatty liver disease in morbidly obese women - a cross-sectional study from Southern India","volume":"16","author":"Atri","year":"2020","journal-title":"Eur Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2026.102107_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.47102\/annals-acadmedsg.V38N1p66","article-title":"Rationale for redefining obesity in Asians","volume":"38","author":"Low","year":"2009","journal-title":"Ann Acad Med Singap"},{"key":"10.1016\/j.beem.2026.102107_bib19","series-title":"Endotext","article-title":"Thin Fat Obesity: The Tropical Phenotype of Obesity","author":"Kapoor","year":"2021"},{"key":"10.1016\/j.beem.2026.102107_bib20","series-title":"The Asia-Pacific perspective: redefining obesity and its treatment","author":"Inoue","year":"2000"},{"key":"10.1016\/j.beem.2026.102107_bib21","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.2147\/DMSO.S248444","article-title":"Optimal body fat percentage cut-off values in predicting the obesity-related cardiovascular risk factors: a cross-sectional cohort study","volume":"13","author":"Macek","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"2","key":"10.1016\/j.beem.2026.102107_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4103\/jhrs.JHRS_2_19","article-title":"Body composition, metabolic characteristics, and insulin resistance in obese and nonobese women with polycystic ovary syndrome","volume":"12","author":"Satyaraddi","year":"2019","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.beem.2026.102107_bib23","first-page":"45","article-title":"Burden of MASLD and liver fibrosis: evidence from Phenome India cohort","author":"Arvind","year":"2026","journal-title":"Lancet Reg Health Southeast Asia"},{"issue":"5","key":"10.1016\/j.beem.2026.102107_bib24","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.23567","article-title":"Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease","volume":"51","author":"Das","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.beem.2026.102107_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cgh.2015.07.024","article-title":"Body fat distribution and risk of incident and regressed nonalcoholic fatty liver disease","volume":"14","author":"Kim","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.beem.2026.102107_bib26","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1111\/jgh.15597","article-title":"Visceral adiposity as a risk factor for lean non\u2013alcoholic fatty liver disease in potential living liver donors","volume":"36","author":"Lee","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.beem.2026.102107_bib27","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/hep.30583","article-title":"PNPLA3, CGI-58, and inhibition of hepatic triglyceride hydrolysis in mice","volume":"69","author":"Wang","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.beem.2026.102107_bib28","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jhep.2012.07.030","article-title":"Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro","volume":"57","author":"Pirazzi","year":"2012","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.beem.2026.102107_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2016.03.011","article-title":"PNPLA3 gene in liver diseases","volume":"65","author":"Tr\u00e9po","year":"2016","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.beem.2026.102107_bib30","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.cgh.2017.04.045","article-title":"Liver and cardiovascular damage in patients with lean nonalcoholic fatty liver disease, and association with visceral obesity","volume":"15","author":"Fracanzani","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.beem.2026.102107_bib31","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/apt.12609","article-title":"PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome","volume":"39","author":"Shen","year":"2014","journal-title":"Aliment Pharm Ther"},{"issue":"9","key":"10.1016\/j.beem.2026.102107_bib32","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/ajg.2015.235","article-title":"Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using proton-magnetic resonance spectroscopy","volume":"110","author":"Wei","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.beem.2026.102107_bib33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2026.102107_bib34","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/ncomms5309","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","volume":"5","author":"Liu","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2026.102107_bib35","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3748\/wjg.v26.i15.1792","article-title":"Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease","volume":"26","author":"Zeng","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.beem.2026.102107_bib36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep4.1124","article-title":"Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long-term follow-up study","volume":"2","author":"Hagstr\u00f6m","year":"2017","journal-title":"Hepatol Commun"},{"issue":"9","key":"10.1016\/j.beem.2026.102107_bib37","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1440-1746.2012.07120.x","article-title":"Cholesteryl ester transfer protein gene polymorphisms increase the risk of fatty liver in females independent of adiposity","volume":"27","author":"Adams","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.beem.2026.102107_bib38","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cmet.2013.07.004","article-title":"DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery","volume":"18","author":"Ahrens","year":"2013","journal-title":"Cell Metab"},{"issue":"12","key":"10.1016\/j.beem.2026.102107_bib39","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1056\/NEJMoa0907295","article-title":"Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease","volume":"362","author":"Petersen","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2026.102107_bib40","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.beem.2026.102107_bib41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/met.2012.0064","article-title":"Genetic variation in the patatin-like phospholipase domain-containing protein-3 (PNPLA-3) gene in Asian Indians with nonalcoholic fatty liver disease","volume":"11","author":"Bhatt","year":"2013","journal-title":"Metab Syndr Relat Disord"},{"issue":"12","key":"10.1016\/j.beem.2026.102107_bib42","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1111\/liv.15758","article-title":"Familial clustering of nonalcoholic fatty liver disease in first-degree relatives of adults with lean nonalcoholic fatty liver disease","volume":"43","author":"Niltwat","year":"2023","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.beem.2026.102107_bib43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s001250051123","article-title":"Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study","volume":"42","author":"Krssak","year":"1999","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.beem.2026.102107_bib44","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.2337\/diabetes.51.7.2005","article-title":"Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha","volume":"51","author":"Itani","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2026.102107_bib45","article-title":"Visceral fat correlates with insulin secretion and sensitivity independent of BMI and subcutaneous fat in Chinese with type 2 diabetes","volume":"14","author":"Huang","year":"2023","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2026.102107_bib46","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11154-014-9301-0","article-title":"Adipocyte dysfunction, inflammation and metabolic syndrome","volume":"15","author":"Kl\u00f6ting","year":"2014","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"10.1016\/j.beem.2026.102107_bib47","doi-asserted-by":"crossref","first-page":"964","DOI":"10.4093\/dmj.2025.0644","article-title":"Hepatic insulin resistance and steatosis in metabolic dysfunction-associated steatotic liver disease: new insights into mechanisms and clinical implications","volume":"49","author":"Truong","year":"2025","journal-title":"Diabetes Metab J"},{"issue":"11","key":"10.1016\/j.beem.2026.102107_bib48","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1111\/j.1572-0241.2005.00297.x","article-title":"Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis","volume":"100","author":"Musso","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.beem.2026.102107_bib49","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1111\/j.1572-0241.2006.00848.x","article-title":"The evolving role of leptin and adiponectin in chronic liver diseases","volume":"101","author":"Tsochatzis","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"22","key":"10.1016\/j.beem.2026.102107_bib50","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1042\/CS20170987","article-title":"Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD?","volume":"131","author":"Gastaldelli","year":"2017","journal-title":"Clin Sci"},{"issue":"5","key":"10.1016\/j.beem.2026.102107_bib51","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2337\/db13-0728","article-title":"LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance","volume":"63","author":"Lan","year":"2014","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.beem.2026.102107_bib52","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jhep.2013.06.004","article-title":"The role of hepassocin in the development of non-alcoholic fatty liver disease","volume":"59","author":"Wu","year":"2013","journal-title":"J Hepatol"},{"issue":"109","key":"10.1016\/j.beem.2026.102107_bib53","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2015.0365","article-title":"The effect of intramuscular fat on skeletal muscle mechanics: implications for the elderly and obese","volume":"12","author":"Rahemi","year":"2015","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.beem.2026.102107_bib54","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.numecd.2017.10.014","article-title":"Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: a prospective pilot study","volume":"28","author":"Duarte","year":"2018","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.beem.2026.102107_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1673517","article-title":"Gut microbial signatures associated with the Indian lean MASLD phenotype","volume":"12","author":"Dey","year":"2025","journal-title":"Front Nutr"},{"key":"10.1016\/j.beem.2026.102107_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2025.102503","article-title":"Gut microbiota and genetic polymorphisms appear to drive disease expression of nonalcoholic fatty liver disease in lean individuals","volume":"15","author":"Anirvan","year":"2025","journal-title":"J Clin Exp Hepatol"},{"issue":"3","key":"10.1016\/j.beem.2026.102107_bib57","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/ajcn\/77.3.612","article-title":"Long-term effect of varying the source or amount of dietary carbohydrate on postprandial plasma glucose, insulin, triacylglycerol, and free fatty acid concentrations in subjects with impaired glucose tolerance","volume":"77","author":"Wolever","year":"2003","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"10.1016\/j.beem.2026.102107_bib58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/met.2019.0038","article-title":"The effect of low glycemic index and glycemic load diets on hepatic fat mass, insulin resistance, and blood lipid panels in individuals with nonalcoholic fatty liver disease","volume":"17","author":"Parker","year":"2019","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.beem.2026.102107_bib59","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3164\/jcbn.11-002FR","article-title":"High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism","volume":"48","author":"Steinbrenner","year":"2011","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.beem.2026.102107_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1335831","article-title":"Association of multiple serum minerals and vitamins with metabolic dysfunction-associated fatty liver disease in US adults: National Health and Nutrition Examination Survey 2017-2018","volume":"11","author":"Guo","year":"2024","journal-title":"Front Nutr"},{"issue":"2","key":"10.1016\/j.beem.2026.102107_bib61","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ajg.2024.02.003","article-title":"Dietary composition and its association with metabolic dysfunction-associated fatty liver disease among Chinese adults: a cross-sectional study","volume":"25","author":"Niu","year":"2024","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.beem.2026.102107_bib62","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1038\/s41598-024-57380-9","article-title":"The contribution of vitamin D insufficiency to the onset of steatotic liver disease among individuals with metabolic dysfunction","volume":"14","author":"Lee","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.beem.2026.102107_bib63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12937-024-00911-x","article-title":"Effects of vitamin D supplementation on liver fibrogenic factors, vitamin D receptor and liver fibrogenic microRNAs in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: an exploratory randomized clinical trial","volume":"23","author":"Ebrahimpour-Koujan","year":"2024","journal-title":"Nutr J"},{"issue":"1","key":"10.1016\/j.beem.2026.102107_bib64","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12986-024-00784-1","article-title":"Glutamine prevents high-fat diet-induced hepatic lipid accumulation in mice by modulating lipolysis and oxidative stress","volume":"21","author":"Zhang","year":"2024","journal-title":"Nutr Metab (Lond)"},{"issue":"3","key":"10.1016\/j.beem.2026.102107_bib65","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4254\/wjh.v16.i3.304","article-title":"Non-alcoholic fatty liver disease and sleep disorders","volume":"16","author":"Bu","year":"2024","journal-title":"World J Hepatol"},{"key":"10.1016\/j.beem.2026.102107_bib66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jpeds.2017.03.007","article-title":"Low and high birth weights are risk factors for nonalcoholic fatty liver disease in children","volume":"187","author":"Newton","year":"2017","journal-title":"J Pedia"},{"issue":"8754","key":"10.1016\/j.beem.2026.102107_bib67","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/0140-6736(91)93068-K","article-title":"Health inequalities among British civil servants: the Whitehall II study","volume":"337","author":"Marmot","year":"1991","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.beem.2026.102107_bib68","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/ajcn\/79.1.6","article-title":"Poverty and obesity: the role of energy density and energy costs","volume":"79","author":"Drewnowski","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.beem.2026.102107_bib69","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200107123450205","article-title":"Neighborhood of residence and incidence of coronary heart disease","volume":"345","author":"Diez Roux","year":"2001","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.beem.2026.102107_bib70","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/QAD.0000000000002161","article-title":"A gathering storm: HIV infection and nonalcoholic fatty liver disease in low and middle-income countries","volume":"33","author":"Kapoor","year":"2019","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.beem.2026.102107_bib71","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhepr.2019.08.002","article-title":"Non-alcoholic fatty liver disease in lean individuals","volume":"1","author":"Albhaisi","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.beem.2026.102107_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113331","article-title":"Recent advances in lean NAFLD","volume":"153","author":"Xu","year":"2022","journal-title":"Biomed Pharm"},{"key":"10.1016\/j.beem.2026.102107_bib73","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2019.06","article-title":"New perspectives on atherogenic dyslipidaemia and cardiovascular disease","volume":"15","author":"Lorenzatti","year":"2020","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.beem.2026.102107_bib74","article-title":"The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: a longitudinal study","volume":"4","author":"Ehimen","year":"2020","journal-title":"Am J Prev Cardiol"},{"issue":"5","key":"10.1016\/j.beem.2026.102107_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003172","article-title":"Socioeconomic gradient of lean diabetes in India: evidence from National Family Health Survey, 2019-21","volume":"4","author":"Behera","year":"2024","journal-title":"PLOS Glob Public Health"},{"issue":"10","key":"10.1016\/j.beem.2026.102107_bib76","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3390\/ijerph13100976","article-title":"Non-obese diabetes and its associated factors in an underdeveloped area of South China, Guangxi","volume":"13","author":"Tang","year":"2016","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"10.1016\/j.beem.2026.102107_bib77","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/1753-0407.12213","article-title":"Prevalence and characteristics of non-obese diabetes in Japanese men and women: the Yuport Medical Checkup Center Study","volume":"7","author":"Kashima","year":"2015","journal-title":"J Diabetes"},{"issue":"6","key":"10.1016\/j.beem.2026.102107_bib78","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jama.2012.9282","article-title":"Association of weight status with mortality in adults with incident diabetes","volume":"308","author":"Carnethon","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.beem.2026.102107_bib79","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ecl.2023.02.006","article-title":"Metabolic-associated fatty liver disease and diabetes: a double Whammy","volume":"52","author":"Kapoor","year":"2023","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.beem.2026.102107_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112387","article-title":"Lean diabetes is one end of the spectrum of type 2 diabetes and not a separate entity","volume":"227","author":"Mohan","year":"2025","journal-title":"Diabetes Res Clin Pr"},{"key":"10.1016\/j.beem.2026.102107_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110699","article-title":"Lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes mellitus: a literature review and meta-analysis","volume":"200","author":"Gao","year":"2023","journal-title":"Diabetes Res Clin Pr"},{"issue":"20","key":"10.1016\/j.beem.2026.102107_bib82","doi-asserted-by":"crossref","first-page":"15473","DOI":"10.3390\/ijms242015473","article-title":"Metabolic-dysfunction-associated steatotic liver disease-its pathophysiology, association with atherosclerosis and cardiovascular disease, and treatments","volume":"24","author":"Yanai","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.beem.2026.102107_bib83","doi-asserted-by":"crossref","DOI":"10.1177\/20406223251378867","article-title":"The relationship between MAFLD and CVD in a health check-up Chinese population: a prospective cohort study","volume":"16","author":"Dou","year":"2025","journal-title":"Ther Adv Chronic Dis"},{"issue":"6","key":"10.1016\/j.beem.2026.102107_bib84","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11906-012-0307-2","article-title":"Mechanisms of lipotoxicity in the cardiovascular system","volume":"14","author":"Wende","year":"2012","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.beem.2026.102107_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101200","article-title":"Sarcopenia - molecular mechanisms and open questions","volume":"65","author":"Wiedmer","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.beem.2026.102107_bib86","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"2","key":"10.1016\/j.beem.2026.102107_bib87","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/cld.900","article-title":"Association of sarcopenia and NAFLD: an overview","volume":"16","author":"Li","year":"2020","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"1","key":"10.1016\/j.beem.2026.102107_bib88","first-page":"48","article-title":"Performance of simple outpatient-based biomarker panels for screening of steatotic liver disease in women with morbid obesity from Southern India","volume":"21","author":"Saha","year":"2025","journal-title":"Touch Endocrinol"},{"issue":"10S","key":"10.1016\/j.beem.2026.102107_bib89","first-page":"S1148","article-title":"Performance characteristics of non-invasive fibrosis scores in lean individuals with non-alcoholic fatty liver disease","volume":"118","author":"Rajvanshi","year":"2023","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.beem.2026.102107_bib90","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.cgh.2019.09.027","article-title":"Performance of simple fibrosis scores in nonobese patients with nonalcoholic fatty liver disease","volume":"18","author":"Fu","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.beem.2026.102107_bib91","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2021.04.044","article-title":"Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis","volume":"75","author":"Selvaraj","year":"2021","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.beem.2026.102107_bib92","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.gastro.2008.03.076","article-title":"Magnetic resonance elastography for the noninvasive staging of liver fibrosis","volume":"135","author":"Huwart","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.beem.2026.102107_bib93","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000326","article-title":"Nonalcoholic fatty liver disease in lean subjects: associations with metabolic dysregulation and cardiovascular risk-a single-center cross-sectional study","volume":"12","author":"Semmler","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"issue":"6","key":"10.1016\/j.beem.2026.102107_bib94","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2018.08.011","article-title":"Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease","volume":"69","author":"Wong","year":"2018","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.beem.2026.102107_bib95","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1440-1746.2012.07165.x","article-title":"Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors","volume":"27","author":"Jin","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.beem.2026.102107_bib96","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jhep.2012.02.023","article-title":"Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"57","author":"Keating","year":"2012","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.beem.2026.102107_bib97","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1136\/gut.2011.242073","article-title":"Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss","volume":"60","author":"Hallsworth","year":"2011","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.beem.2026.102107_bib98","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2009.05.033","article-title":"Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome","volume":"51","author":"Abid","year":"2009","journal-title":"J Hepatol"},{"issue":"18","key":"10.1016\/j.beem.2026.102107_bib99","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.beem.2026.102107_bib100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41575-020-00408-y","article-title":"Therapeutic pipeline in nonalcoholic steatohepatitis","volume":"18","author":"Vuppalanchi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.beem.2026.102107_bib101","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc19-0167","article-title":"Role of vitamin E for nonalcoholic steatohepatitis in patients with type 2 diabetes: a randomized controlled trial","volume":"42","author":"Bril","year":"2019","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.beem.2026.102107_bib102","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s13300-018-0401-9","article-title":"Pioglitazone improved insulin sensitivity and first phase insulin secretion among obese and lean people with diabetes: a multicenter clamp study","volume":"9","author":"Qian","year":"2018","journal-title":"Diabetes Ther"},{"issue":"5","key":"10.1016\/j.beem.2026.102107_bib103","doi-asserted-by":"crossref","first-page":"E930","DOI":"10.1152\/ajpendo.00522.2004","article-title":"Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissue","volume":"288","author":"Rasouli","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2026.102107_bib104","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M15-1774","article-title":"Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial","volume":"165","author":"Cusi","year":"2016","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.beem.2026.102107_bib105","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2008.06.047","article-title":"Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis","volume":"135","author":"Aithal","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.beem.2026.102107_bib106","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jamainternmed.2016.9607","article-title":"Thiazolidinediones and advanced liver fibrosis in nonalcoholic steatohepatitis: a meta-analysis","volume":"177","author":"Musso","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.beem.2026.102107_bib107","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.31843","article-title":"Saroglitazar, a PPAR-\u03b1\/\u03b3 agonist, for treatment of NAFLD: a randomized controlled double-blind phase 2 trial","volume":"74","author":"Gawrieh","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.beem.2026.102107_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.70144","article-title":"Effectiveness of saroglitazar in MASLD patients: a prospective, real-world assessment of liver and metabolic health","volume":"9","author":"Gupta","year":"2026","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/j.beem.2026.102107_bib109","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.beem.2026.102107_bib110","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1038\/s41467-024-47919-9","article-title":"The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis","volume":"15","author":"Cooreman","year":"2024","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.beem.2026.102107_bib111","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/dom.13584","article-title":"Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes","volume":"21","author":"Cusi","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"10.1016\/j.beem.2026.102107_bib112","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00125-018-4675-2","article-title":"Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study","volume":"61","author":"Eriksson","year":"2018","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.beem.2026.102107_bib113","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2337\/dc19-0641","article-title":"Empagliflozin effectively lowers liver fat content in well-controlled type 2 diabetes: a randomized, double-blind, phase 4, placebo-controlled trial","volume":"43","author":"Kahl","year":"2020","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.beem.2026.102107_bib114","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.17305\/bb.2025.12203","article-title":"Effect of SGLT2 inhibitors on liver fat content: a meta-analysis","volume":"25","author":"Ge","year":"2025","journal-title":"Biomol Biomed"},{"issue":"1","key":"10.1016\/j.beem.2026.102107_bib115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.ajkd.2024.08.002","article-title":"Glucagon-like peptide-1 receptor agonists: new evidence of kidney and cardiovascular protection from the FLOW and SELECT trials","volume":"85","author":"Taal","year":"2025","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.beem.2026.102107_bib116","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1210\/endrev\/bnac018","article-title":"Glucagon-like peptide-1 receptor-based therapeutics for metabolic liver disease","volume":"44","author":"Yabut","year":"2023","journal-title":"Endocr Rev"},{"issue":"10019","key":"10.1016\/j.beem.2026.102107_bib117","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.beem.2026.102107_bib118","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.beem.2026.102107_bib119","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S2213-8587(22)00070-5","article-title":"Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial","volume":"10","author":"Gastaldelli","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2026.102107_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156113","article-title":"Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis","volume":"164","author":"Karakasis","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.beem.2026.102107_bib121","doi-asserted-by":"crossref","DOI":"10.1155\/ije\/6430023","article-title":"Resmetirom: the first disease-specific treatment for MASH","author":"Mousa","year":"2025","journal-title":"Int J Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2026.102107_bib122","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"issue":"10390","key":"10.1016\/j.beem.2026.102107_bib123","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0140-6736(23)00634-7","article-title":"Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial","volume":"401","author":"Verrastro","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.beem.2026.102107_bib124","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13370","article-title":"The magnitude and progress of lean body mass, fat-free mass, and skeletal muscle mass loss following bariatric surgery: a systematic review and meta-analysis","volume":"23","author":"Nuijten","year":"2022","journal-title":"Obes Rev"},{"key":"10.1016\/j.beem.2026.102107_bib125","article-title":"Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts","author":"Huo","year":"2025","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.beem.2026.102107_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101288","article-title":"Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: an updated meta-analysis","volume":"29","author":"Wongtrakul","year":"2024","journal-title":"Ann Hepatol"},{"issue":"3","key":"10.1016\/j.beem.2026.102107_bib127","doi-asserted-by":"crossref","first-page":"433","DOI":"10.5009\/gnl210167","article-title":"Metabolic dysfunction-associated fatty liver disease predicts long-term mortality and cardiovascular disease","volume":"16","author":"Moon","year":"2022","journal-title":"Gut Liver"},{"issue":"5","key":"10.1016\/j.beem.2026.102107_bib128","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1007\/s12072-024-10716-z","article-title":"Liver and cardiovascular outcomes in lean non\u2013alcoholic fatty liver disease: an updated systematic review and meta\u2013analysis of about 1 million individuals","volume":"18","author":"Souza","year":"2024","journal-title":"Hepatol Int"},{"issue":"6","key":"10.1016\/j.beem.2026.102107_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102569","article-title":"Cardiovascular morbidity and mortality in lean vs. non\u2013lean MASLD: a comprehensive meta\u2013analysis","volume":"49","author":"Nso","year":"2024","journal-title":"Curr Probl Cardiol"},{"issue":"5","key":"10.1016\/j.beem.2026.102107_bib130","first-page":"461","article-title":"High prevalence of metabolic obesity in India: the ICMR-INDIAB national study (ICMR-INDIAB-23)","volume":"161","author":"Mohan","year":"2025","journal-title":"Indian J Med Res"},{"issue":"6","key":"10.1016\/j.beem.2026.102107_bib131","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MED.0000000000000935","article-title":"Emerging concepts in the diagnosis and management of metabolically associated steatotic liver disease","volume":"32","author":"Das","year":"2025","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.beem.2026.102107_bib132","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrd3625","article-title":"RNA therapeutics: beyond RNA interference and antisense oligonucleotides","volume":"11","author":"Kole","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/j.beem.2026.102107_bib133","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1017\/S0007114509990468","article-title":"Dietary carbohydrates, glycaemic load, food groups and newly detected type 2 diabetes among urban Asian Indian population in Chennai, India (Chennai Urban Rural Epidemiology Study 59)","volume":"102","author":"Mohan","year":"2009","journal-title":"Br J Nutr"},{"issue":"4","key":"10.1016\/j.beem.2026.102107_bib134","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.16496","article-title":"Management of metabolic dysfunction-associated steatotic liver disease (MASLD)-an expert consensus statement from Indian diabetologists\u2019 perspective","volume":"27","author":"Zargar","year":"2025","journal-title":"Diabetes Obes Metab"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:39:48Z","timestamp":1783381188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X26000291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":134,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1521690X26000291"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2026.102107","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lean metabolic dysfunction-associated steatotic liver disease: Current insights and knowledge gaps","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2026.102107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102107"}}